Per Stirling Capital Management’s JPMorgan Chase JPM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.16M Buy
3,942
+185
+5% +$56.1K 0.13% 125
2025
Q4
$1.21M Sell
3,757
-7
-0.2% -$2.17K 0.14% 114
2025
Q3
$1.19M Buy
3,764
+62
+2% +$18.4K 0.14% 108
2025
Q2
$1.07M Buy
3,702
+5
+0.1% +$1.28K 0.14% 109
2025
Q1
$907K Buy
3,697
+15
+0.4% +$3.82K 0.13% 120
2024
Q4
$883K Sell
3,682
-157
-4% -$36.6K 0.13% 116
2024
Q3
$810K Buy
3,839
+383
+11% +$80.7K 0.11% 132
2024
Q2
$699K Sell
3,456
-561
-14% -$110K 0.11% 123
2024
Q1
$805K Buy
4,017
+110
+3% +$19.8K 0.13% 101
2023
Q4
$665K Buy
3,907
+286
+8% +$43.3K 0.12% 104
2023
Q3
$525K Buy
3,621
+8
+0.2% +$1.2K 0.11% 117
2023
Q2
$525K Sell
3,613
-30
-0.8% -$4.13K 0.11% 118
2023
Q1
$475K Sell
3,643
-905
-20% -$124K 0.1% 118
2022
Q4
$610K Buy
+4,548
New +$576K 0.11% 108

Other funds holding JPM

Per Stirling Capital Management's JPM Position: Q1 2026 in Review

Per Stirling Capital Management increased its JPMorgan Chase (JPM) stake by 4.9% in Q1 2026, buying an estimated $56.1K and bringing the position to 3,942 shares worth $1.16M. The position accounts for 0.13% of the portfolio, ranked #125.

Per Stirling Capital Management first reported a position in JPM in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.21M in Q4 2025. 5,054 funds tracked by Wall St. Rank hold JPM as of Q1 2026.

  • Per Stirling Capital Management held 3,942 shares of JPMorgan Chase worth $1.16M as of Q1 2026.
  • Per Stirling Capital Management bought 185 JPMorgan Chase shares in Q1 2026, an estimated $56.1K.
  • JPMorgan Chase made up 0.13% of Per Stirling Capital Management's portfolio in Q1 2026, its #125 holding.
  • Per Stirling Capital Management first reported a position in JPMorgan Chase in Q4 2022 and has held it in 14 quarters since.
  • Per Stirling Capital Management's JPMorgan Chase position peaked at $1.21M in Q4 2025.
  • 5,054 funds tracked by Wall St. Rank held JPMorgan Chase as of Q1 2026.

Based on Per Stirling Capital Management's 13F filing for Q1 2026, filed 12 May 2026.